Cargando…
In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases
BACKGROUND: Acinetobacter baumannii has emerged as a major nosocomial pathogen worldwide. Many of the circulating strains exhibit multi-drug resistance remaining consistently susceptible only to polymyxins. In-vitro studies have reported that polymyxins combined with carbapenems, rifampicin or azith...
Autores principales: | Wareham, David W, Bean, David C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1484489/ https://www.ncbi.nlm.nih.gov/pubmed/16630352 http://dx.doi.org/10.1186/1476-0711-5-10 |
Ejemplares similares
-
Emergence of multidrug-resistant Acinetobacter baumannii producing OXA-23 Carbapenemase in Qatar
por: Rolain, J.-M., et al.
Publicado: (2016) -
Carbapenemase OXA-423: A Novel OXA-23 Variant in Acinetobacter baumannii
por: Yang, Zhenghai, et al.
Publicado: (2020) -
Multidrug-Resistant Acinetobacter baumannii Harboring OXA-24 Carbapenemase, Spain
por: Acosta, Joshi, et al.
Publicado: (2011) -
Hetero- and adaptive resistance to polymyxin B in OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates
por: Barin, Juliana, et al.
Publicado: (2013) -
Worldwide Dissemination of the bla(OXA-23) Carbapenemase Gene of Acinetobacter baumannii(1)
por: Mugnier, Pauline D., et al.
Publicado: (2010)